Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Sep 15, 2016 $30.64 $31.00 $30.03 $30.21 316 300
Sep 14, 2016 $29.97 $31.00 $29.97 $30.67 332 200
Sep 13, 2016 $30.81 $31.28 $29.55 $29.84 252 500
Sep 12, 2016 $29.53 $31.48 $29.53 $31.36 520 400
Sep 09, 2016 $30.12 $30.45 $29.50 $29.78 287 700
Sep 08, 2016 $30.35 $30.81 $30.06 $30.58 288 400
Sep 07, 2016 $30.25 $30.50 $29.64 $30.35 432 700
Sep 06, 2016 $30.50 $30.80 $29.45 $30.03 409 500
Sep 02, 2016 $30.37 $30.95 $29.74 $30.81 430 800
Sep 01, 2016 $29.74 $30.30 $29.55 $29.98 409 700
Aug 31, 2016 $29.46 $29.85 $28.92 $29.77 291 500
Aug 30, 2016 $29.26 $29.68 $29.11 $29.51 152 800
Aug 29, 2016 $29.57 $29.79 $28.49 $29.25 170 300
Aug 26, 2016 $29.36 $30.00 $28.79 $29.39 219 900
Aug 25, 2016 $28.78 $29.39 $27.75 $29.35 427 900
Aug 24, 2016 $30.02 $30.73 $28.69 $28.95 267 500
Aug 23, 2016 $30.30 $30.70 $29.53 $29.89 302 400
Aug 22, 2016 $30.74 $31.19 $29.52 $30.21 251 200
Aug 19, 2016 $30.10 $31.42 $29.72 $30.51 308 100
Aug 18, 2016 $29.77 $30.23 $29.31 $30.14 262 000
Aug 17, 2016 $29.19 $29.82 $29.00 $29.71 219 300
Aug 16, 2016 $29.86 $30.24 $28.99 $29.16 329 300
Aug 15, 2016 $29.70 $30.30 $29.70 $30.10 422 600
Aug 12, 2016 $29.84 $29.95 $28.85 $29.50 211 800
Aug 11, 2016 $29.19 $30.37 $28.98 $30.05 383 400
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT